Tuberculosis (TB) Blood Test
for Using the QuantiFERON-TB Gold Test (QFT-G) for Detecting Mycobacterium
tuberculosis Infection, United States (exit
QuantiFERON®-TB Gold test (QFT-G), a
whole-blood test for use in detecting Mycobacterium tuberculosis infection, received Food and
Drug Administration (FDA) approval in 2005.
QFT-G may now be used in ALL occupational settings in place
of a skin test.
Bureau of Quality Assurance (BQA) has granted a state-wide variance allowing
any hospital or Community Based Residential Facility (CBRF) to use QFT-G as
an alternative to the Mantoux TB skin test for tuberculosis screening.
Hospitals and CBRFs are the only two providers in Wisconsin for which the
TB skin test is specified in the requirements. For all other types of
licensed providers that require screening for infectious diseases (nursing
homes, facilities for the developmentally disabled, etc.), the TB skin test
is not specified. Thus, all other providers may also choose to screen for
tuberculosis infection using QFT-G in place of the TB skin test without any
special variance or waiver.
The Tuberculosis Program can provide additional information about the
use of QuantiFERON®-TB Gold in Wisconsin.
Facilities in/near Wisconsin offering QuantiFERON®-TB Gold
Facility names are provided for convenience purposes only;
their use does not imply endorsement by the Wisconsin Department of Health Services.
(Call the individual facility for details)
(exit DHS) - multiple locations (800-877-7016)
- Beloit Clinic - Beloit
- Consultants Laboratory - Fond du Lac WI
- Dynacare Laboratories - Milwaukee WI
- Meriter Hospital - Madison WI (608/267-6529)
- SMDC Clinical Laboratory - Duluth MN
- St Elizabeth Hospital Laboratory - Appleton WI (920-738-2136)
- St Vincent Hospital - Green Bay
- West Bend Clinic - West Bend WI (262-334-3451 ext 2304 or 2365)
March 04, 2014